Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesRefocusing of B-cell responses following a single amino acid substitution in an antigenA novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentTransferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen.Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine.Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.Generation of female genital tract antibody responses by local or central (common) mucosal immunizationSystemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humansSpecific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretionsRecombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responsesAntibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunizationLocal and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humansNasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines.Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cellsEnhancement of mucosal immunization with virus-like particles of simian immunodeficiency virusOrally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infectionIntranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infectionsMicrobiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures.Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protectionBacillus subtilis: a temperature resistant and needle free delivery system of immunogens.Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates.Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice.Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.
P2860
Q22241377-E9742E24-2EA8-41E2-8BEA-9AEE83B42315Q28367028-ABB4553D-9898-43ED-AFBB-CCFB0083DF78Q28476693-62FA94B7-FA5B-48D7-906F-004F592C261DQ30468622-ECFB7003-E591-4066-94C9-F1158224A114Q33308325-8DCE6453-6308-4162-BCBA-E98EEFB89CA8Q33591055-6DD391AA-48A6-4DC5-B767-CA0511E91A36Q33591251-F2D78370-0B0E-48C3-BBC4-6D4D92C0CB4EQ33592158-9AC2DB3E-3C93-4380-A97E-58D51B38D6DAQ33599589-CF2E96D2-0D45-456A-B16E-63B90A33781CQ33756767-966DD148-3606-4932-B5D4-4A27275BFC59Q33769451-3973DD1C-588A-4CDC-8C3B-37ADB5FAF33FQ33784891-597A91C3-9A6D-48C4-BEED-B5E9820274E0Q33846577-82B9B848-636B-44AA-BC45-0769C09FAA5FQ34001107-44FD7F9B-3E23-4AA7-9359-7E999ACCD5FDQ34003167-E25C5AAC-938F-444E-A583-61F81F127A32Q34005612-AD0286E0-4B90-47F1-8EC0-F756FABC3B0BQ34008126-12BE8D81-4DDF-49BE-B35F-15931082F6C0Q34009698-3331D960-7DCC-4CB1-A12B-977BC4E939E8Q34186333-949AAF12-2ED3-44FA-9D35-C3402D5687C5Q34354995-FF3090B3-5B90-40CF-ADFA-B9BF09A3EE84Q34434903-9520159E-7C28-4650-895D-714F72D9CF86Q34465399-77E2683E-E1B0-41EE-BB1E-02F22E46B556Q34708547-CB7BB77D-D5FD-4470-98EE-21C4EED2280CQ34717658-AAE71FE4-F1DD-4DD4-901F-461E99CAA850Q34744920-48E90C17-710E-4799-BC0D-CE30B6987558Q34941937-796E4C65-816E-411E-AEBA-48E382CB5614Q34976881-DEE7CD1E-BD7A-40E5-912B-FDE16FA650F7Q34982527-D05311E5-F654-4EA7-BD53-1DBAC345CD36Q35019917-A5F89497-CF2A-44C2-87D4-3D42A11979A0Q35550898-41861ED6-7678-4FFA-8DFE-5C1B18418D14Q35923577-F5044791-BEB2-4DE4-B342-843AB968BA02Q36095558-75797B2B-E351-478C-B659-9AA9E856F8B3Q36391905-19DA1253-F3C1-479F-80C2-3133FC0FB771Q36464264-2311F5BC-18D2-4592-9869-DE9894A12361Q37187433-F5E13CA0-5B34-466E-8141-58F3BB2877D9Q37617455-D87690AC-4F81-478F-8E8D-D46984894967Q40344808-52143A77-B183-4B85-A27C-79764B7050F5Q45111137-471DD7AE-A8FF-4DC7-8F4C-4C957D9D2E9CQ47120596-6C23B9D3-73E9-400F-95F0-621F8CA2A13B
P2860
Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@ast
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@en
type
label
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@ast
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@en
prefLabel
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@ast
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@en
P2093
P2860
P921
P1476
Antibodies and antibody-secret ...... toxin B subunit or conjugates
@en
P2093
C Czerkinsky
E L Johansson
K Eriksson
M Fredriksson
P2860
P304
P407
P50
P577
1998-02-01T00:00:00Z